A subsidiary of San Diego-based pharmaceutical company Cardium Therapeutics Inc. has launched a life insurance program for men with prostate cancer.

Cardium (NYSE: CXM) is developing several medical products, including topical wound care gels, nutritional supplements and heart disease medications. On September 16, stock was trading at 81 cents per share — a 13 percent increase from the day previous. Its market capitalization is $5.9 million.

The company’s life insurance subsidiary, called LifeAgain Insurance Solutions Inc., is designed for men between the ages of 45 and 65 who have prostate cancer — a group the company said might be otherwise be unable to receive life insurance.

— SDBJ Staff Report